Hiroki Yokota

22PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsNanoscale characterisationElectrical circuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 28, 2026
Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447.

|May 27, 2026
Correction: Xu et al. Nucleosome Clustering as a Biomarker and Mechanistic Switch for Reprogramming Cells. Cells 2026, 15, 113.

|Feb 27, 2026
Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer.

Shengzhi Liu, Di Wu, Kazumasa Minami

|Jan 28, 2026
Nucleosome Clustering as a Biomarker and Mechanistic Switch for Reprogramming Cells.

Zhaoyuan Xu, Yinzhi Xu, Baiyan Li

|Feb 13, 2025
Electrical Stimulation Generates Induced Tumor-Suppressing Cells, Offering a Potential Option for Combatting Breast Cancer and Bone Metastasis.

Changpeng Cui, Yinzhi Xu, Xue Xiong

|Jun 27, 2024
P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis.

Changpeng Cui, Qingji Huo, Xue Xiong

Pageof 4

Frequent Collaborators

16 joint publications

Baiyan Li

4 joint publications

Kazumasa Minami

4 joint publications

Marxa L Figueiredo

3 joint publications

Melissa L Fishel